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ABSTRACT 26 
 27 
The screening of candidate compounds and natural products for anthelmintic activity is important 28 
for discovering new drugs against human and animal parasites. We previously validated in 29 
Caenorhabditis elegans a microfluidic device (‘chip’) that records non-invasively the tiny 30 
electrophysiological signals generated by rhythmic contraction (pumping) of the worm’s pharynx. 31 
These electropharyngeograms (EPGs) are recorded simultaneously from multiple worms per chip, 32 
providing a medium-throughput readout of muscular and neural activity that is especially useful for 33 
compounds targeting neurotransmitter receptors and ion channels. Microfluidic technologies have 34 
transformed C. elegans research and the goal of the current study was to validate hookworm and 35 
Ascaris suum host-stage larvae in the microfluidic EPG platform. A. ceylanicum and A. caninum 36 
infective L3s (iL3s) that had been activated in vitro generally produced erratic EPG activity under 37 
the conditions tested. In contrast, A. ceylanicum L4s recovered from hamsters exhibited robust, 38 
sustained EPG activity, consisting of three waveforms: (1) conventional pumps as seen in other 39 
nematodes; (2) rapid voltage deflections, associated with irregular contractions of the esophagus 40 
and openings of the esophogeal-intestinal valve (termed a ‘flutter’); and (3) hybrid waveforms, 41 
which we classified as pumps. For data analysis, pumps and flutters were combined and termed 42 
EPG ‘events.’ EPG waveform identification and analysis were performed semi-automatically using 43 
custom-designed software. The neuromodulator serotonin (5-hydroxytryptamine; 5HT) increased 44 
EPG event frequency in A. ceylanicum L4s at an optimal concentration of 0.5 mM. The 45 
anthelmintic drug ivermectin (IVM) inhibited EPG activity in a concentration-dependent manner. 46 
EPGs from A. suum L3s recovered from pig lungs exhibited robust pharyngeal pumping in 1 mM 47 
5HT, which was inhibited by IVM. These experiments validate the use of A. ceylanicum L4s and A. 48 
suum L3s with the microfluidic EPG platform, providing a new tool for screening anthelmintic 49 
candidates or investigating parasitic nematode feeding behavior. 50 
 51 
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Abbreviations: 52 
5HT, 5-hydroxytryptamine (serotonin); aL3, activated L3; CaS, calf serum; CF50, time at which 50% 53 
of the total number of EPG events had occurred after switching perfusate; CS, canine serum; E 54 
spike (in EPG recording), onset of muscle contraction during a pump; EI, esophogeal-intestinal; 55 
EPG, electropharyngeogram; FITC-BSA, bovine serum albumin–fluorescein isothiocyanate 56 
conjugate; FF, flutter fraction; Glu-Cl, glutamate-gated chloride channel; GSM, S-methyl-57 
glutathione; HS, human serum; iL3, infective L3; IPSP, inhibitory postsynaptic potential; IVM, 58 
ivermectin; M9, M9 buffer; NS, normal saline; PBS-ps, PBS containing 100 U penicillin and 100 59 
µg/ml streptomycin; PC, polycarbonate; PDMS, polydimethylsiloxane; PE, polyethylene; RPMI-c, 60 
complete RPMI medium; R spike (in EPG recording), muscle relaxation during a pump; SNR, 61 
signal-to-noise ratio; STH, soil-transmitted helminth. 62 
 63 
1. Introduction 64 
 65 
Intestinal parasites cause considerable disease burdens in humans and other animals. Soil-66 
transmitted helminth (STH) infections are concentrated in sub-Saharan Africa, the Americas, China 67 
and East Asia, where over a billion people carry these parasites. Infections with hookworm 68 
(Ancylostoma spp. and Necator americanus), roundworm (Ascaris lumbricoides) and whipworm 69 
(Trichuris trichuria) cause physical and cognitive stunting in children, and chronic ill health and 70 
impaired productivity in adults (Bethony et al., 2006; Brooker, 2010). Likewise, gastrointestinal 71 
nematode infections in livestock cause poor productivity and economic losses in both high- and 72 
low-income nations (Pfukenyi and Mukaratirwa, 2013; van der Voort et al., 2016). 73 
Current anthelmintic (anti-worm) drugs have limitations. For example, some parasites (e.g., 74 
human whipworm, T. trichuria), are relatively insensitive to all available anthelmintic drugs (Keiser 75 
and Utzinger, 2008). Additionally, increasing drug resistance in parasites is weakening the 76 
effectiveness of current anthelmintics, especially in veterinary medicine (Kaplan, 2004; Coles et al., 77 
2006). Drugs are failing in both livestock and companion animals (Wolstenholme et al., 2015). In 78 
humans, reports of reduced anthelmintic efficacy are not widespread but, given the nature of 79 
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natural selection, are expected to increase (Vercruysse et al., 2011). It is widely agreed that new 80 
anthelmintic treatments are urgently needed and that the current drug development pipeline is 81 
inadequate (Geary et al., 2015).  82 
Our research addresses two key aspects of the search for new anthelmintics: (1) the nature of 83 
the physiological readout used to detect anthelmintic bioactivity and (2) the nematode species 84 
used for screening. When screening candidate molecules on cultured worms, typical endpoints 85 
include developmental arrest, impaired motility or death (Geary et al., 2015). These phenotypes 86 
are easily scored but provide little insight into underlying mechanisms. For high-throughput 87 
screening, the free-living nematode Caenorhabditis elegans offers convenience, low cost and 88 
molecular-genetic tools (Holden-Dye and Walker, 2014; Burns et al., 2015), but has yet to produce 89 
a commercial product (Geary et al., 2015). Hits identified in C. elegans must subsequently be 90 
tested on the targeted parasitic species or close relatives. Alternatively, parasitic nematodes can 91 
be used in primary screens (e.g., Bulman et al., 2015), at higher cost and lower throughput than C. 92 
elegans, but with more direct relevance to targeted species. 93 
Many current anthelmintic drugs act on proteins involved in electrical signaling—94 
neurotransmitter receptors and ion channels—and these molecules remain valuable targets for 95 
anthelmintic drug development (Wolstenholme, 2011; Taman and Azab, 2014). Therefore, a 96 
screening method that reads out electrophysiological function could help prioritize and characterize 97 
hits when seeking new anthelmintics, and provide more mechanistic insight than nonspecific 98 
phenotypes such as death. We addressed this need by integrating the fields of microfluidics (the 99 
precise control of fluids and samples at sub-millimeter scale) and electrophysiology to develop a 100 
device (‘chip’) that noninvasively records, in real time and medium throughput, the tiny electrical 101 
signals emitted by nematode muscles and neurons (Lockery et al., 2012). This device contributes 102 
to an ongoing revolution in C. elegans research fueled by microfluidic technologies (Bakhtina and 103 
Korvink, 2014). Our device records electropharyngeograms (EPGs) from eight worms 104 
simultaneously during exposure to control or test substances. EPG recordings reveal electrical 105 
activity of muscles and neurons of the pharynx (sometimes termed the esophagus), the muscular 106 
pump used for feeding (Raizen and Avery, 1994; Trojanowski et al., 2016). In C. elegans, 107 
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pharyngeal pumping draws bacteria into the digestive tract, whereas intestinal parasites ingest 108 
host digesta, blood and/or tissue (Wells, 1931; Kalkofen, 1970; Khuroo, 1996; Avery and You, 109 
2012). Pharyngeal pumping frequency is often used to assess nematodes’ physiological status 110 
(Hughes et al., 2011), but is typically counted only for brief (10 to 60 s) periods, and by eye, which 111 
can be inaccurate. In contrast, EPG recordings can provide millisecond-resolution data on 112 
thousands of pumps (see 2.9), providing exceptional statistical power. A microfluidic chip that 113 
records EPGs from single worms has also been developed in the laboratory of Prof. Lindy Holden-114 
Dye (C. Hu et al., 2013; Y. Hu et al., 2014). 115 
We have extensively validated the 8-channel microfluidic EPG platform in C. elegans, including 116 
characterization of the dose-dependent inhibition of pumping by anthelmintic drugs and 117 
distinguishing wild type from drug-resistant worms (Lockery et al., 2012; Weeks et al., in 118 
preparation). A one-channel version of this chip is now commercially available (‘ScreenChip’; 119 
http://nemametrix.com). The goal of the present study was to adapt the technology and software 120 
for use with parasitic nematodes that impact human and animal health. Specifically, we optimized 121 
methods for two classes of human STHs: (1) hookworms, including Ancylostoma ceylanicum, a 122 
significant human parasite in SE Asia (Traub, 2013); and (2) Ascaris suum, a zoonotic model for 123 
the human parasite, A. lumbricoides, which may be the same species (Leles et al., 2012). Our 124 
experiments demonstrate successful adaptation of the microfluidic EPG platform for use with host-125 
stage STH larvae, providing a new tool for anthelmintic research and investigations of nematode 126 
feeding behavior. 127 
 128 
2. Materials and methods 129 
 130 
2.1. Animal care 131 
 132 
 Animals were housed and treated in accordance with institutional animal care and use 133 
committee guidelines at The George Washington University (protocol A270), USDA/ARS (protocol 134 
13-019) and UC San Francisco (protocol AN098756-02). 135 
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 136 
2.2. In vitro activation of infective L3s 137 
 138 
The western Maryland (wmd) strain of A. caninum (US National Parasite Collection No. 139 
106970) was maintained in beagles, and infective L3 worms (iL3s) were harvested from charcoal 140 
cultures of dog feces (Krepp et al., 2011). An Indian strain of A. ceylanicum (USNPC No. 102954) 141 
was maintained in Syrian golden hamsters (Garside and Behnke, 1989) and iL3 were stored in BU 142 
buffer (Hawdon and Schad, 1991) at room temperature for up to 5 wk until use. iL3 of both species 143 
were activated under host-like conditions as described previously (Hawdon et al., 1999). Briefly, 144 
~250 decontaminated iL3 were incubated at 37°C, 5% CO2, for 24 h in 96-well tissue culture plates 145 
containing 0.1 ml RPMI-1640 tissue culture medium (Mediatech, Inc. 10-041-CV, Manassas, VA) 146 
with 25 mM HEPES (pH 7.0), and supplemented with 100 U penicillin, 100 µg/ml streptomycin 147 
(penicillin-streptomycin solution, Global Cell Solutions, North Garden, VA) and 100 µg/ml 148 
gentamycin (Sparhawk Laboratories, Lenexa, KS). This medium is designated RPMI-complete 149 
(RPMI-c). iL3 were activated by adding 15 mM S-methyl-glutathione (GSM, Sigma M4139) and 150 
10% (v/v) of human serum (HS; Sigma H4522, St. Louis, MO) or a <10 kDa ultrafiltrate of canine 151 
serum (CS; recovered from whole blood collected from post-infection dogs and stored at -20 °C; 152 
Hawdon et al., 1995) to the RPMI-c. After 24 h incubation, worms were returned to RPMI-c. 153 
Feeding, an indicator of successful activation (Hawdon and Schad, 1990), was assayed in A. 154 
caninum by incubating worms for 2-3 h in 5 mg/ml of FITC-BSA (Sigma A9771) in RPMI-c. Larvae 155 
with FITC-BSA in the intestinal tract were used for EPG recordings. 156 
 157 
2.3. Collecting A. ceylanicum L4s from hamsters 158 
 159 
To obtain developing parasitic stages, 4- to 5-week-old Syrian golden hamsters were 160 
inoculated orally using a feeding needle with ~2000 A. ceylanicum iL3s. At ~72 h post-infection, 161 
hamsters were killed by CO2 inhalation, the small intestine was removed, split longitudinally, and 162 
placed in warm PBS with 100 U penicillin and 100 µg/ml streptomycin (PBS-ps) at 37 oC to allow 163 
worms to release from the intestine. L4s were individually selected based on size and the 164 
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characteristic buccal capsule. L4s were rinsed twice in warm PBS-ps and incubated in RPMI-c at 165 
37oC until use. 166 
 167 
2.4. Collecting A. suum L3s from swine 168 
 169 
The preparation of infective A. suum eggs and inoculation of two pigs from the Beltsville 170 
Swine Herd were completed as described previously (Urban et al., 2013). Seven days after 171 
inoculation with 15,000 infective eggs, the lungs were removed and mixed with an equal volume of 172 
37 °C normal saline in a Waring blender container w ith rotating cutting blades, and homogenized 173 
for approximately 20 s to produce a tissue suspension of fragments of ~0.5 cm3. Host-stage L3s 174 
were isolated from the lung tissue using an agar-gel method (Urban et al., 2013), transferred to 175 
RPMI-c and kept in a 37°C, 5% CO 2, incubator until use. For EPG recordings, 10% (v/v) calf serum 176 
(CaS; Lonza BioWhittaker 14-401F, Walkersville, MD, USA) was added to RPMI-c. 177 
 178 
2.5. Microfluidic EPG devices 179 
 180 
Devices (‘chips’) were fabricated at the University of Oregon using standard soft 181 
lithographic methods (Xia et al., 1996; Xia and Whitesides, 1998). Each chip had eight recording 182 
modules (see Fig. 1A). Channel dimensions in the PDMS (polydimethylsiloxane) layer were 183 
modified to optimize EPG recordings from different nematode species and stages. It was not 184 
possible to developmentally synchronize parasitic worms to the same extent as C. elegans, so 185 
they had more size variation. Variation in length was not an important factor whereas worm 186 
diameter was, as it affects the seal resistance and therefore the signal-to-noise ratio (SNR; 187 
Lockery et al., 2012). For A. ceylanicum L4s, chips had a channel height of 45 or 55 µm and width 188 
of 60 µm. For A. suum L3s, channel height was 75 µm and width was 60 µm. For aL3s, which were 189 
smaller, we used a new design in which channel width tapered gradually from 60 µm to 30 or 20 190 
µm. Height of the tapered channels was 25 or 35 µm. Depending on diameter, aL3s lodged at 191 
different distances along the tapered channel. In all designs, the ‘worm trap’ (see Fig. 1B) was 13 192 
µm wide, too narrow to permit worms to pass. 193 
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 194 
2.6. Loading and recording from EPG chips 195 
 196 
 Chips were preloaded with M9 buffer (Stiernagle, 2006) containing 0.01% Tween (Fisher 197 
Scientific BP337-500); Tween facilitated propelling the long, coiling larvae along the network of 198 
channels that distribute worms into recording channels (see Fig. 1A). This solution also avoided 199 
short-circuiting of electrical signals by RPMI-c left on the surface of the PDMS during loading. 200 
Worms were gently propelled into position by applying pressure into the inlet port via a syringe and 201 
polyethylene (PE) tubing (PE-BPE-T25, Instech Laboratories, Inc., Plymouth Meeting, PA, USA) 202 
filled with the M9-Tween solution. Worms lodged either head- or tail-first in the recording modules, 203 
which determined signal polarity (Lockery et al., 2012). By convention (Raizen and Avery, 1994), 204 
EPG traces in the Figures are displayed with the ‘E’ spike of the waveform (indicating onset of 205 
muscle contraction) upward and the ‘R’ spike (muscle relaxation) downward. During the E spike, 206 
the extracellular voltage at the head is positive relative to the tail (Raizen and Avery, 1994). 207 
 The loaded chip was positioned on a stereomicroscope (Leica MZ16 or Olympus VMZ) or 208 
inverted microscope (Nikon TMS or Zeiss Axio Observer A1). Polycarbonate tubing (PC; 209 
CTPC450-900-5, Paradigm Optics, Vancouver, WA, USA) was inserted into the inlet port via a 210 
short length of 1.5 mm diameter stainless steel tubing (New England Small Tube, Litchfield, NH, 211 
USA) that also served as the reference electrode. The other end of the tubing led to a syringe on a 212 
syringe pump (Harvard Apparatus PHD 2000; Holliston, MA). The PC tubing was connected to the 213 
reference electrode and syringe by short lengths of PE tubing. Solutions were perfused through the 214 
chip at 6 µl/min and solution changes were effected by manually switching the tubing to a different 215 
syringe on the pump. The resultant electrical artifact was masked in the Figures. The time between 216 
switching syringes and the new perfusate reaching worms was < 60 s. A silver metal electrode was 217 
inserted into a port distal to each worm trap, which led to differential amplifiers that measured 218 
voltage relative to the reference electrode. Chips were typically maintained between 34 - 38 °C via 219 
a heater mounted on the aluminum dock holding the chip, consisting of a 1 Ω power resistor affixed 220 
to the dock by its aluminum heat sink. Heat sink compound was used to facilitate heat transfer 221 
between the aluminum and glass contacts and foam insulation was used to reduce heat loss. The 222 
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heater was powered from a rheostat-controlled 5 V DC power supply. Temperature was monitored 223 
by a miniature thermocouple inserted between the PDMS layer and glass substrate of the chip, 224 
which led to a digital thermometer (Signstek 6802II, Wilmington, DE, USA). The rheostat was 225 
adjusted manually to maintain temperature.  226 
 227 
2.7. Drug solutions 228 
 229 
Stocks of serotonin creatine sulfate monohydrate (Sigma H7752; St. Louis, MO) were 230 
prepared in M9 buffer at 40 mM and held in small aliquots at -20°C until use. Each day of an 231 
experiment, a fresh aliquot was thawed and diluted to the desired concentration. Working solutions 232 
of 5HT were used within 70 min of preparation. Stocks of ivermectin (10 mM; Sigma 8898) were 233 
prepared in 100% dimethyl sulfoxide (DMSO; Fisher D-136; Fair Lawn, NJ), held at -20°C until use 234 
and diluted to the working concentration each day. 235 
 236 
2.8. Electrophysiological and video recordings 237 
 238 
EPG signals were acquired as described in Lockery et al. (2012) with few modifications. 239 
AC amplifiers (A-M Systems model 1700 or 3500; Carlsborg, WA) had low-and high-frequency 240 
cut-offs of 1 and 500 Hz, respectively, and a 60 Hz notch filter. Signals were digitized at 2.5 241 
kHz/channel and displayed in Spike2 software (version 7.06a, Cambridge Electronic Design). 242 
Data were acquired continuously during each experiment. An additional channel was used as a 243 
keystroke-controlled event marker. Because the amplitude of EPG signals varied (see 3; Table 244 
1) voltage scales were not included in figures, and traces were scaled to have similar peak-to-245 
peak amplitudes. 246 
Videos of A. ceylanicum pharyngeal behavior were acquired using (1) a smartphone 247 
video application to film a video monitor displaying the worm (30 frames/s) or (2) a CMOS 248 
camera (DFK 23UM021; The Imaging Source, Charlotte, NC, USA) attached to the microscope 249 
(up to 80 frames/s). Video and EPG recordings were synchronized using Igor Pro (WaveMetrics, 250 
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Lake Oswego, OR, USA). Audio for Fig. 4 was generated by modulating the volume of broad-251 
band, low-frequency noise by the voltage amplitude of the EPG trace. 252 
 253 
2.9. EPG Data Analysis 254 
 255 
A 60 min EPG recording of a single larva generating EPG events at 1 Hz (Fig. 5A) 256 
contains ~3600 events, far beyond the ability of an investigator to analyze by hand. Accordingly, 257 
we used an automated spike recognition system modified from that in Lockery et al. (2012). 258 
Recordings acquired in Spike2 were down-sampled to 500 Hz, imported into Igor Pro as text 259 
files, and analyzed using a pump-recognition algorithm developed for EPG recordings from C. 260 
elegans, which will be published elsewhere (JC Weeks, KJ Robinson, SR Lockery and WM 261 
Roberts, unpublished data). Parasite movements within recording modules were more vigorous 262 
than for C. elegans, causing EPG waveforms to vary in amplitude and shape between worms 263 
and in the same worm over time. This variability provided greater challenges for automated 264 
pump identification than EPG recordings made by transecting C. elegans and sucking the 265 
exposed pharynx into a pipette (forming a seal with relatively high electrical resistance and well-266 
defined geometry), the conditions used by Dillon et al. (2009) for their ‘AutoEPG’ pump-267 
recognition program. To accommodate EPG variability, the algorithm used in the present study 268 
compensated for changes in EPG amplitude during the recording and automatically optimized 269 
recognition of each worm’s EPG waveforms. Attributes including the time, duration and 270 
amplitude of each pump were collected automatically by the software. 271 
Because A. ceylanicum L4s produced a second EPG waveform that we have termed a 272 
flutter, and a hybrid waveform with features of both pumps and flutters (see 3.3), the C. elegans 273 
pump-recognition algorithm was modified to identify and count clusters of three or more closely-274 
spaced pairs of positive and negative peaks as a single flutter. Hybrid waveforms having only 275 
two closely-spaced pairs of positive and negative peaks, or multiple unpaired peaks, were 276 
counted as one ‘pump’.  277 
To test the accuracy of pump and flutter identifications obtained by the automated 278 
analysis versus those made by human observers, two individuals familiar with EPG recordings 279 
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(JCW and WMR) scored 1 min of baseline data (beginning at t = -12 min before switching 280 
solutions) from two A. ceylanicum L4s selected randomly from each of the 12 experimental 281 
groups in Figs. 5 - 7 (i.e., 24 min of EPG data from 24 different worms; each worm scored by 282 
one observer). Scorers were blinded to the automated identification of the waveforms. In the 24 283 
min of data analyzed, the scorers identified 1836 events (pumps + flutters; mean event 284 
frequency = 1.27 Hz) whereas the automated detection algorithm identified 1655 events (mean 285 
event frequency = 1.15 Hz). Thus, the algorithm may have underestimated mean event 286 
frequency by ~10%. Combining all events identified by either the algorithm or the scorers, and 287 
assuming that the scorers’ made correct identifications, there was 86% concordance (true 288 
positives), 2% false positives, and 12% false negatives. The primary causes of mismatches 289 
were: (1) the EPG signal became too small to distinguish from background noise (poor SNR), or 290 
(2) an event was obscured by a brief electrical artifact of unknown cause. The concordance 291 
between human scorers and the algorithm in identifying waveforms as pumps vs. flutters was 292 
84%; because pumps and flutters formed a continuum (Fig. 3B), identifying a waveform as one 293 
or the other (by algorithm or human scorer) was sometimes arbitrary so this discordance was 294 
unsurprising. 295 
EPG recordings were rejected if the signal was deemed too noisy for reliable identification 296 
of pumps by a human observer or if the worm turned around in the microfluidic channel during the 297 
recording. The remaining recordings were passed to the automated analysis program, which 298 
recorded the time, duration and amplitude of each pump or flutter. For each recording, the baseline 299 
event frequency (fbaseline) was determined by counting the number of events during the 10 min 300 
immediately before switching the perfusion source (-12 min < t < -2 min). To improve consistency 301 
of the results, worms with low baseline event frequencies (fbaseline < 0.45 Hz) were eliminated from 302 
further analysis. Eliminating worms with low fbaseline also eliminated the large variance that is 303 
introduced into the calculation of normalized event frequency (see below) when the denominator is 304 
close to zero. Approximately 10% of worms were excluded by this criterion. 305 
The graphs in Figs 5-7 show mean event frequencies averaged across worms (i.e., 306 
ensemble-averaged waveforms), with shading drawn to indicate ± 1 S.E.M., where n is the number 307 
of worms in the ensemble. The event frequency, fevent(t), was first calculated separately for each 308 
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worm by binning the time axis (1 s bin width), counting all events (pumps + flutters) in each bin, 309 
and smoothing the result using a Gaussian weighted sliding window with  = 30 s. The smoothed 310 
event frequency vs. time curves were then averaged across worms to determine the mean and 311 
S.E.M. at each time point.  312 
Normalized event frequency was calculated as fevent(t)/fbaseline. We also computed the ‘flutter 313 
fraction’ (FF), defined as the proportion of events that were flutters:  314 
 FF(t) = fflutter(t)/(fflutter(t) + fpump(t)) 315 
where the pump frequency, fpump(t), and flutter frequency, fflutter(t), were computed separately and 316 
smoothed as described above for fevent(t) before taking the ratio. To reduce the effects of baseline 317 
variability between worms, each worm’s baseline flutter fraction between -12 and -2 min was 318 
subtracted before averaging across worms. 319 
To compare statistically the time required for drug effects, we computed the cumulative 320 
fraction (CF) of EPG events that occurred following drug onset, with CF50 defined as the time at 321 
which 50% of the total number of events occurred during the 45 or 60 min observation period after 322 
drug onset. Drugs that rapidly blocked pumping thus produced small CF50 values; drugs that had 323 
no effect on pumping had CF50 values equal to one half of the post-drug observation time. This 324 
definition was used because EPG activity of individual worms often stopped and restarted multiple 325 
times after drug addition, causing ambiguity in measures such as the time for the mean event 326 
frequency to fall by 50%. The cumulative fraction method avoids this ambiguity because it rises 327 
monotonically with time. 328 
 329 
3. Results and discussion 330 
 331 
3.1. EPG recording method for parasitic larvae 332 
 333 
FIGURE 1 HERE 334 
Fig. 1A shows the design of the 8-channel microfluidic EPG chip used in these 335 
experiments, with channel dimensions optimized for the species and stages studied (see 2.5). 336 
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Each worm was positioned in a recording module (Fig. 1B), randomly oriented either head- or tail-337 
first, which determines signal polarity (Lockery et al., 2012). All EPG recordings shown here are 338 
displayed with the E spike (see 3.2) directed upward. 339 
 340 
3.2. EPG recordings from A. ceylanicum and A. caninum iL3s activated in vitro 341 
 342 
In Ancyclostoma spp., eggs in the feces of infected hosts are deposited onto soil and 343 
develop into infective L3s (iL3s), which do not feed. After entering a suitable host, iL3s shed their 344 
enveloping cuticle (‘exsheathment’) and commence feeding. Exposure to suitable conditions in 345 
vitro (e.g., serum components, glutathione analogs, elevated temperature and CO2) can ‘activate’ 346 
iL3s to transform into host-stage L3s and initiate feeding (e.g., Hawdon and Schad, 1990; Tritten et 347 
al., 2012). Activated L3s are henceforth termed aL3s. This method for obtaining host-stage larvae 348 
is simpler and less expensive than sacrificing mammals to obtain worms.  349 
We tested whether aL3s of A. ceylanicum and A. caninum were suitable subjects for 350 
screening compounds using the EPG platform, with the performance criteria being the generation 351 
of: (1) recognizable EPG waveforms (confirmed by simultaneous visual observation of pharyngeal 352 
pumping movements) with good SNR and (2) EPG activity that continued at a relatively regular 353 
frequency for at least 60 min while worms were in chips. These criteria were based on C.elegans 354 
adults, which pump for hours at ~4-5 Hz in the presence of 5HT, permitting sensitive detection of 355 
anthelmintic bioactivity (Lockery et al., 2012 and unpublished data). EPGs were recorded from A. 356 
ceylanicum and A. caninum aL3s in RPMI-c or M9 buffer, with various additives (5HT, GSM and 357 
blood sera) that stimulate feeding (Roche et al., 1971; Hawdon and Schad, 1990). We tested M9 358 
because we use it routinely for EPG recordings in C. elegans (Lockery et al., 2012). 359 
FIGURE 2 HERE 360 
Pharyngeal pumping and the expected EPG waveforms were observed in aL3s of both 361 
hookworm species (Fig. 2). A. ceylanicum aL3 recordings were obtained primarily at room 362 
temperature whereas, in all other experiments, worms were maintained at closer to host 363 
temperature. The characteristic pump waveform reported in many nematode species (e.g., Raizen 364 
and Avery, 1994; Sheriff et al., 2002; Tahseen et al., 2003; Hu et al., 2014) was apparent, with 365 
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pronounced E and R spikes marking the excitation (contraction) and repolarization, respectively, of 366 
pharyngeal muscle. Most aL3s produced 1 or more clearly-recognizable pump waveforms during 367 
EPG recordings: 80% (41 of 51) of A. ceylanicum and 79% (46 of 58) of A. caninum. However, we 368 
did not successfully identify conditions that stimulated sustained pumping. For most (51 of 58) A. 369 
caninum EPG recordings, the worms were first incubated in FITC-BSA and selected for strong 370 
intestinal labeling, indicating commencement of feeding (Hawdon and Schad, 1990). Occasionally, 371 
aL3s exhibited regular pumping (Fig. 2Bii) but sustained activity was an exception and pumping 372 
was normally infrequent and erratic. The inclusion of serum and 5HT in RPMI-c, and recording at 373 
warmer temperatures, seemed the most effective in stimulating pumping.  374 
TABLE 1 HERE  375 
Table 1 presents the amplitude and duration of pharyngeal pumping EPG waveforms. The 376 
two species of aL3s had the smallest pump amplitudes. Pump amplitude is affected by variables 377 
including the tightness of fit of a worm in its recording module, the strength of each contraction and 378 
the size of the pharynx (larger muscles emit more current). The aL3s were the smallest worms 379 
from which we recorded (see 2.5), which may account for their smaller EPG amplitudes. Despite 380 
the smaller signals, the SNR was satisfactory (Fig. 2). Regarding pump duration, Table 1 shows 381 
that A. ceylanicum aL3s had significantly longer pump durations than A. caninum aL3s, which 382 
perhaps resulted from the former recordings being obtained at lower temperature. 383 
In summary, A. ceylanicum and A. caninum aL3s did not meet our performance criteria for 384 
assaying anthelmintic bioactivity in EPG chips (criterion 2). Pardoxically, EPG activity was weak 385 
even in aL3s with strong FITC-BSA labeling, indicating that the worms had been feeding in culture. 386 
Possibly, FITC-BSA labeling resulted from a relatively low level of pumping, which fell below our 387 
performance criterion. Or, pumping may have been robust in culture but inhibited when aL3s were 388 
tested in chips; however, because A. ceylanicum L4s pump robustly in chips (see 3.3), any such 389 
inhibition was not a general phenomenon. Finally, other investigators have reported that larvae 390 
activated in vitro may differ from their counterparts developing in vivo (Joachim et al., 2001; Lin et 391 
al., 2013). This potential issue could be addressed by testing host-stage L3s obtained from 392 
hamsters. On the positive side, ~80% of aL3s produced at least some pumping in EPG chips and 393 
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further attempts to optimize conditions are warranted. However, in the present study, we set aside 394 
aL3s and focused on A. ceylanicum L4s obtained from hamsters. 395 
 396 
3.3. EPG recordings in A. ceylanicum L4s 397 
 398 
FIGURE 3 HERE 399 
Fig. 3A shows EPG activity in A. ceylanicum L4s removed from the small intestine of a 400 
hamster ~72 h post-infection (see 2.3). Unlike aL3s, these worms exhibited sustained activity for 401 
prolonged periods of time in RPMI-c with 20% CS, even in the absence of 5HT. In contrast to the 402 
clocklike pumping at ~4-5 Hz in C. elegans treated with 5HT (Lockery et al., 2012), EPG activity in 403 
A. ceylanicum L4s was more bout-like, with an average frequency of ~1 Hz (see 3.4). Pump 404 
waveforms in A. ceylanicum L4s resembled those in other nematodes. Table 1 shows EPG pump 405 
amplitude and duration values for these worms. Mean amplitude was the largest of any nematodes 406 
tested in this study and pump duration was the longest of the nematodes tested at warmer 407 
temperatures.  408 
Unexpectedly, EPGs from A. celanicum L4s included, in addition to pump waveforms (Fig. 409 
3Bi), a zig-zag-shaped waveform (Fig. 3Bii) and a waveform that appeared to be a hybrid of the 410 
first two (Fig. 3Biii). Based on video analysis of esophageal (pharyngeal) behaviors (see 3.4), we 411 
named the zig-zag-shaped waveforms ‘flutters.’ Fig. 3C illustrates typical patterns of EPG activity 412 
in six different worms; flutters occurred singly (worm 1) or in bouts (worms 4, 6). The initial voltage 413 
deflection in a flutter had the same polarity as the E spike of a pump. The number of deflections 414 
per flutter ranged from 3 to 8, with 4 to 6 being most common, and flutters had longer durations 415 
than pumps. The hybrid waveform resembled a pump with flutter-like deflections between the E 416 
and R spikes. In fact, pump and hybrid waveforms appeared as a continuum, as seen by 417 
comparing Figs. 3Bi and 3Biii. In Fig. 3Bi, all but one of the pumps had small, flutter-like deflections 418 
between the E and R spikes, which were qualitatively similar to the deflections in hybrid waveforms 419 
(Fig. 3Biii) but of smaller amplitude. A consistent feature of hybrid waveforms was that the peak 420 
amplitude of upward-going deflections became smaller over the course of the waveform whereas, 421 
during flutters, the amplitude of upward-going deflections remained the same or increased. 422 
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Because the hybrid waveforms always had obvious E and R spikes, and corresponded to 423 
pharyngeal pumps in video analysis (see 3.4), they were catgorized as pumps during our analysis 424 
(see 2.9). 425 
Remarkably, over 50 years ago, Roche et al. (1962) reported similar waveforms during 426 
EPG recordings (termed ‘electroesophagrams’ by these investigators) from A. caninum adults. ‘A 427 
waves’ were recognizable as pump waveforms and confirmed as such by visual observation. ‘B 428 
waves’ appeared identical to what we here term flutters. Hybrid waveforms were not mentioned. 429 
Roche et al. reported that B waves corresponded with “..uncoordinated inefficient movement of the 430 
esophageal musculature,” and were most frequent at the start of recordings and during “conditions 431 
which are presumably unfavorable to the worm, such as trauma and irritation” (Roche et al., 1962). 432 
However, these authors did not speculate on the behavioral function that this esophageal behavior 433 
might serve.  434 
 435 
3.4. Video analysis of esophageal behaviors in A. ceylanicum L4s 436 
 437 
To correlate specific behaviors with different EPG waveforms, we made simultaneous EPG 438 
and video recordings of individual A. ceylanicum L4s. Observations below were based on slow-439 
motion review of >2.5 h of video recordings of A. ceylanicum L4s in chips. Anatomical structures 440 
examined in the videos were (from anterior to posterior) the buccal capsule, esophagus, 441 
esophageal bulb (slight enlargement of the posterior esophagus), esophogeal-intestinal (EI) valve 442 
and the anteriormost region of the intestine (Nichols, 1956; Matsusaki et al., 1964, 1965). The term 443 
‘esophagus’ is used here synonomously with ‘pharynx.’ 444 
FIGURE 4 HERE 445 
Fig. 4 shows simultaneous video and EPG recordings from a representative A. ceylanicum 446 
L4. At rest, the esophageal lumen and EI valve were closed and the EPG recording was flat. As 447 
seen in Fig. 4A, characteristic pump waveforms in EPGs corresponded to esophageal pumps. 448 
Each pump was marked by dilation of the esophageal lumen (presumably via contraction of radial 449 
muscles surrounding the esophagus; Mapes, 1965; Brownlee et al., 1995b), which appeared 450 
synchronous along the length of the esophagus. Dilation was followed by closure of the lumen 451 
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(presumably via relaxation of the radial muscles) and opening of the EI valve. In other parasitic 452 
nematodes, muscles fibers attach to the EI valve and there is innervation of the valve region 453 
(Mapes, 1965; Brownlee et al., 1995b), suggesting that valve openings may be neutrally controlled 454 
rather than passive responses to increased intra-esophageal pressure. Neural control of the EI 455 
valve is also suggested by our observation of ‘twitches’ and valve openings in the absence of other 456 
esophageal movements (data not shown). In contrast to esophageal dilation, there was an 457 
anterior-to-posterior progression in lumenal closure, with the EI valve opening when closure 458 
reached the end of the esophagus. This sequence propelled esophageal contents posteriorly, 459 
through the EI valve into the intestine. An additional video of esophageal pumping and valve 460 
movements in an A. ceylanicum L4 is provided as Supplemental Content. 461 
In contrast to pumps, flutter EPG waveforms (Fig. 3Bii) corresponded to series of small, 462 
rapid contractions along the esophagus and repeated openings and closings of the EI valve (Fig. 463 
4B), which prompted our use of the term ‘flutter’ for this behavior. The observed behavior thus 464 
aligns with the “uncoordinated inefficient” esophageal contractions reported in A. caninum adults 465 
by Roche et al. (1962). The small size and brief duration of esophageal dilations during flutters 466 
suggests that minimal suction was produced. In videos, hybrid EPG waveforms (Fig. 3Biii) clearly 467 
corresponded to pumps, with prominent dilation of the esophageal lumen, but accompanied by 468 
rapid, localized contractions of the esophagus. These behavioral observations support the 469 
classification of hybrid waveforms as pumps during data analysis (see 2.9). 470 
It was possible to link some EPG voltage signals with esophageal movements. As 471 
expected, E and R spikes in pump waveforms corresponded to initiation and termination of 472 
esophageal dilation. Larger-amplitude pump waveforms were accompanied by more forceful 473 
esophageal contractions. The source of repetitive voltage deflections during flutters was less clear. 474 
The negative-going phase of deflections bore some resemblance to inhibitory postsynaptic 475 
potentials (IPSPs) produced in C. elegans pharyngeal muscles by motoneuron M3, via glutamate-476 
gated chloride channels (Glu-Cls) (Franks et al., 2006). These IPSPs, which occur between E and 477 
R spikes, help terminate pharyngeal contraction. In this case, we would expect hybrid waveforms 478 
in A. ceylanicum L4s to have shorter durations than conventional pumps, but we did not observe 479 
this relationship (e.g., Fig. 3Bi and Biii; data not shown). Another possibility is that the voltage 480 
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deflections during flutters reflected action potentials occurring asynchronously throughout 481 
esophageal muscules, corresponding to the localized contractions and valve openings. The 482 
relationship between voltage deflections and muscle contractions was most apparent when 483 
observing the esophagus while listening to the audio track of the EPG recording (Fig. 4B). The 484 
rapid voltage deflections during some pumps and all hybrid EPG waveforms (Fig. 3Bi and Biii) may 485 
likewise have resulted from localized contractions superimposed on lumenal dilation. The possible 486 
behavioral function of flutters is considered at the end of section 3.7. 487 
In previous experiments using the EPG platform, we relied exclusively on pharyngeal 488 
pumping as the readout of anthelmintic bioactivity. The presence of flutters in A. ceylanicum L4s 489 
raised the issue of whether flutters were as valid as pumps in quantifying effects of excitatory and 490 
inhibitory drugs on EPG activity. The presence of flutters also required that we modify the detection 491 
algorithm used to identify pumps in EPG recordings, to independently identify and count pumps 492 
and flutters. The latter was successfully accomplished (see 2.9) and we show below (see 3.6 and 493 
3.7) that combining pumps and flutters into one category termed ‘EPG events’ produced the same 494 
results as counting pumps alone, while providing more statistical power.  495 
 496 
3.5. Effects of perfusate-switching and 5HT on EPG activity in A. ceylanicum L4s 497 
 498 
FIGURE 5 HERE 499 
Fig. 5A shows the protocol used for experiments with A. ceylanicum L4s, which includes 500 
switching perfusate in mid-experiment. During the 1-to-2 min interruption of perfusate flow during 501 
the switch, worms drifted backward from the worm trap (Fig. 1B) and were propelled back into the 502 
trap after flow was re-established. Accordingly, we first tested whether the mechanical disturbance 503 
caused by switching perfusate disturbed EPG activity.  504 
Figs. 5B and 5C show the frequency of EPG events over time in two groups of L4s. One 505 
group (brown) was perfused with control medium without interruption while the other group (black) 506 
was switched from control medium to the same medium at t = 0. Raw data in Fig. 5B show that 507 
event frequency remained steady at ~ 0.8 - 1 Hz in both groups. The same data are shown 508 
normalized in Fig. 5C to compensate for minor variations between worms in baseline event 509 
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frequency; only normalized data are shown in subsequent Figures. Fig. 5D compares the 510 
cumulative fraction of events occuring after the time of the switch (t = 0), with no significant 511 
difference between the two groups at CF50 (our standard index of of comparison). Fig. 5E shows 512 
the proportion of events that were flutters (‘flutter fraction’; see 2.9; baseline flutter fractions are 513 
provided in Figure Legends) during the experiment. Flutter fraction remained relatively stable in 514 
both groups including in the switched group; this group showed a decline in flutter fraction starting 515 
~30 min post-switch, for unknown reasons presumably unrelated to the switch. When flutters were 516 
omitted from the CF50 analysis, results similar to those in Fig. 5D were obtained (data not shown). 517 
In summary, the mechanical disturbance cause by switching perfusate perturbed neither 518 
EPG event frequency nor the flutter fraction in A. ceylanicum L4s. 519 
FIGURE 6 HERE 520 
Although A. ceylanicum L4s produced sustained EPG activity in the absence of 5HT, we 521 
tested whether activity was enhanced by 5HT. 5HT stimulates pumping in C. elegans and other 522 
free-living and parasitic nematodes (Brownlee et al., 1995a; Tahseen et al., 2003; Chiang et al., 523 
2006; Song and Avery, 2012), with a wide effective range of ~0.005 to 20 mM reported in intact 524 
worms. Fig. 6A shows the effects of 5HT on normalized EPG event frequency in A. ceylanicum 525 
L4s. Switching the perfusate to 5HT-containing medium had several effects. First, there was a 526 
transient decrease in EPG activity immediately following the switch, which was most pronounced in 527 
the highest-concentration group (2 mM 5HT); based on Fig. 5, this inhibition resulted from the 5HT 528 
and not the switch. By ~10 to 15 min post-switch, EPG activity recovered to near baseline levels in 529 
all groups. The most striking effect of 5HT was an increase (initially, > 2-fold) in EPG event 530 
frequency in the 0.5 mM 5HT group, which peaked by ~25 min and then waned (Fig. 6A). The 15-531 
25 min latency for 5HT to exert maximal effect on EPG event frequency is similar to that in C. 532 
elegans (unpublished data). CF50 values did not differ significantly among treatment groups, except 533 
for the 0.5 mM 5HT group (Fig. 6B). Results similar to those in Fig. 6 were obtained when only 534 
pumps were analyzed (data not shown). Figs. 6A and 6B thus demonstrate a U-shaped 535 
concentration dependence of 5HT’s effect on EPG event frequency, with peak effectiveness 536 
(among the tested concentrations) at 0.5 mM 5HT. 537 
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Fig. 6C presents flutter fraction data for the different 5HT groups. In the two highest 538 
concentration groups (1 and 2 mM 5HT), the switch to 5HT caused a rapid but transient increase in 539 
flutter fraction, which recovered to near baseline levels after ~10 min. Subsequently, flutter fraction 540 
was generally reduced from baseline levels for the remainder of the experiment, in all groups (Fig. 541 
6C). In summary, 0.5 mM 5HT, but not higher or lower concentrations, increased EPG activity in A. 542 
ceylanicum L4s.  543 
 544 
3.6. Inhibition of EPG activity by IVM in A. ceylanicum L4s 545 
 546 
FIGURE 7 HERE 547 
For human hookworm infection, the most efficacious anthelmintics are albendazole and 548 
mebendazole (Keiser and Utzinger, 2010) but IVM also kills A. ceylanicum (Behnke et al., 1993; 549 
Richards et al., 1995; Hu et al., 2013). IVM was originally developed as a veterinary anthelmintic 550 
and is still used as such (Geary, 2005); acting on Glu-Cls, it causes paralysis and death of 551 
intestinal nematodes (Wolstenholme and Rogers, 2005). We tested IVM on A. ceylanicum L4s 552 
rather than a benzimidazole because IVM terminates EPG activity in C. elegans (Lockery et al., 553 
2012) and a concern that benzimidazoles’ mode of action (microtubule destabilization) may be too 554 
slow to produce an EPG phenotype during a 45-60 min recording. 555 
Fig. 7A displays representative recordings in A. ceylanicum L4s, showing that EPG activity 556 
was terminated by switching the perfusate to 1 µM IVM. Ivermectin caused EPG signals to 557 
decrease in amplitude, as also seen in C. elegans (Lockery et al., 2012). Most activity ceased by 558 
10-15 min after IVM onset. Fig. 7B demonstrates that this inhibition was concentration-dependent. 559 
In control larvae, normalized EPG event frequency was stable for the duration of the experiment. 560 
The two highest concentrations of IVM tested (1 and 10 µM) rapidly terminated EPG activity 561 
whereas, in 0.1 µM IVM, activity continued for ~30 min. CF50 values differed significantly between 562 
all of the groups (Fig. 7C) and similar results were obtained when only pumps were counted (data 563 
not shown). Fig. 7D shows that flutter fraction was stable in the control group and that the IVM 564 
groups showed no consistent pattern after the switch. Notably, IVM did not cause a sudden 565 
increase in flutter fraction, as seen for the high-concentration 5HT groups (Fig. 6C). Thus, IVM 566 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
21 
 
experiments did not provide additional insight into whether flutters represent aversive responses 567 
(Roche et al., 1962). 568 
The micromolar concentrations of IVM used here and in A. suum experiments (see 3.8) are 569 
higher than needed to kill intestinal worms in vivo (Behnke et al., 1993) and hence might be 570 
considered ‘unphysiological.’ In the case of A. ceylanicum, Richards et al. (1995) discuss why 571 
higher concentrations are needed in vitro, including the desire for rapid endpoints (e.g., cessation 572 
of pharyngeal activity within 30 min; Fig. 7B) as opposed to the days to weeks of lower-dose 573 
exposure that cause in vivo endpoints such as reduced egg production or worm expulsion.  574 
In C. elegans, 5HT influences pharyngeal behavior via multiple neural pathways and 5HT 575 
receptor subtypes (Song and Avery, 2012; Trojanowski et al., 2016). Comparable information is 576 
not available for hookworms. The details of 5HT’s effects in A. ceylanicum remain to be 577 
determined, but the enhancement of EPG activity by 5HT treatment resembles that seen in other 578 
nematodes. The finding that A. ceylanicum L4s generated sustained EPG activity without 5HT in 579 
the medium is advantageous for experiments. 5HT treatment is an unnatural stimulus that 580 
overrides normal feeding circuitry and, by driving supra-normal EPG activity, could potentially 581 
decrease sensitivity to anthelmintic compounds. Blood serum in the medium (20% CS in RPMI-c) 582 
apparently provided a sufficient feeding-inducing stimulus in A. ceylanicum L4s, without exogenous 583 
5HT (Roche et al., 1971; Hawdon and Schad, 1990). A minor caveat is that sera may contain low 584 
levels of 5HT (Mothersill et al., 2010). The ability of a natural food stimulus to drive pharyngeal 585 
activity is also seen in C. elegans, a bacteriovore, in which perfusing edible bacteria through an 586 
EPG chip evokes sustained pharyngeal pumping, but at a lower frequency than with 10 mM 5HT 587 
(unpublished data). Thus, in both A. ceylanicum and C. elegans, maximal pharyngeal pump 588 
frequencies are achieved with 5HT treatment rather than natural feeding stimuli. 589 
These experiments with 5HT and IVM provide some potential insight into the behavioral 590 
significance of flutters. Depending on feeding habit, nematodes show a variety of 591 
esophageal/pharyngeal behaviors (e.g., Chiang et al., 2006; Bhatla et al., 2015; Wilecki et al., 592 
2015). However, other than A. ceylanicum L4s (current study), and A. caninum adults (Roche et 593 
al., 1962), flutter waveforms and behaviors have not, to our knowledge, been reported. It is thus 594 
unknown how widespread this behavior is. Roche et al. (1962) proposed that flutters are 595 
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responses to aversive conditions; in the present experiments, an increase in flutter fraction might 596 
reveal such a response. The only instance in which flutter fraction increased after switching 597 
perfusate was for the two highest concentrations of 5HT (Figs. 5E, 6C and 7D). In C. elegans, 5HT 598 
increases sensitivity to aversive stimuli (Chao et al., 2004), consistent with a potentially aversive 599 
response in A. ceylanicum. It is perhaps surprising that IVM did not evoke a similar response, 600 
because of its toxicity to nematodes. One difficulty in interpreting responses to 5HT and IVM is 601 
that, as drugs that perturb electrophysiological signaling, they may activate behaviors 602 
inappropriately. Thus, the increase in flutter fraction caused by 5HT may be irrelevant to normal 603 
behavior. Clearer results would be obtained by recording EPGs while presenting putatively 604 
aversive stimuli with more physiological relevance, such as low pH, high temperature or physical 605 
injury. 606 
Nevertheless, some potential functions of flutters can be considered. Unlike pumps, flutters 607 
produced little esophageal dilation, suggesting that they were relatively ineffective in sucking blood 608 
or tissue into the buccal cavity or esophagus. During an endoscopic study of hookworms feeding in 609 
the human intestine, Barakat et al. (2012) described three behaviors: “…(1) the mucosal piercing 610 
process, which is a mechanical, quickly spinning, body-pushing movement that caused piercing 611 
within a few seconds…; (2) repeated feeding by the same worm within a short time...;(3) graceful 612 
smooth movement after fixation of the worm to the mucosa, which was maintained during the rest 613 
of the meal…”. While positioned in microchannels, A. ceylanicum L4s often produced sinuous body 614 
movements, lengthening and shortening of the body, and sometimes spinning movements, which 615 
may have some relationship to behaviors expressed in vivo. Based on visual review of video 616 
recordings of A. ceylanicum L4s in chips, we did not detect a reliable correspondence between 617 
pumps, flutters and any whole-body movements, but a definitive conclusion would require more 618 
detailed analysis. An intriguing possibility is that flutters are associated with the mucosal piercing 619 
process, a behavior specially adapted for blood feeders. 620 
Another potential function of flutters relates to esophageal secretion. Several prominent 621 
secretory glands empty into the hookworm esophagus and buccal cavity (Eiff, 1966; Smith, 1976). 622 
The excretory/secretary products of hookworms include diverse anticoagulants, 623 
immunomodulatory agents, proteases and other molecules (Mulvenna et al., 2009), with both 624 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
23 
 
anticoagulants and digestive enzymes being present specifically in esophageal glands (Feng et al., 625 
2007; Jiang et al., 2011). In an excellent description of feeding behavior in vivo, Kalkofen (1970) 626 
reported that A. caninum adults suck a large bolus of host tissue into the buccal capsule every 6 – 627 
15 min, which is digested and sucked into the esophagus and intestine. Potentially, esophageal 628 
contractions during flutters could help release digestive enzymes and anticoagulants and/or mix 629 
them with ingesta. Esophageal flutters and associated EI valve openings might also permit the 630 
retrograde flow of digestive enzymes from the intestine to the esophagus. To resolve such 631 
questions, movements of esophageal and intestinal contents could be visualized by introducing 632 
fluorescent microspheres or oil droplets into the medium (Kiyama et al., 2012; Bhatla et al., 2015).  633 
 634 
3.7. EPG recordings in Ascaris suum L3s 635 
 636 
We next tested A. suum L3s, obtained from pig lungs 7 d after infection (see 2.4), in the 637 
microfluidic EPG platform. This stage was selected because it required only minor modification of 638 
channel size in the microfluidic EPG chips (see 2.5). Our access to A. suum larvae was limited, so 639 
experiments were less comprehensive than for A. ceylanicum.  640 
FIGURE 8 HERE 641 
 Fig. 8A shows representative EPG waveforms recorded in A. suum L3s. The waveforms 642 
were characteristic of pharyngeal pumping in other nematodes (see 3.2) and visual observation 643 
confirmed their correspondence to pharyngeal pumps (data not shown). No flutter waveforms or 644 
behaviors were observed. Table 1 shows pump amplitude and duration data for A. suum L3s.  645 
A. suum exhibits 5HT immunoreactivity and has multiple 5HT receptor isoforms (Johnson 646 
et al., 1996; Huang et al., 2002); in the absence of 5HT, pharyngeal preparations do not exhibit 647 
spontaneous pumping, but do so in the presence of 10 to 1000 µM 5HT (Brownlee et al., 1995a, 648 
1997). Fig. 8B shows the effect of 1 mM 5HT on A. suum L3s; there was little or no EPG activity 649 
under control conditions whereas 5HT evoked sustained pumping. The onset of robust pumping 650 
was relatively rapid (~5 to 15 min). 651 
The preferred treatment for human ascariasis is albendazole, with mebendazole and 652 
pyrantel as alternatives (Keiser and Utzinger, 2008). In vitro, IVM has been shown to kill or inhibit 653 
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pharyngeal pumping in A. suum (Brownlee et al., 1997; Dmitryjuk et al., 2014) and, in pigs, it is 654 
effective against both larval and adult A. suum (Borgsteede et al., 2007). Fig. 8C shows the effect 655 
of IVM on pumping in A. suum L3s. During the baseline period, in 1 mM 5HT, mean pump 656 
frequency was 1.16 + 0.20 Hz (S.E.M; n = 6 worms). For comparison, (Brownlee et al., 1995a) 657 
reported a mean pump frequency of 0.5 Hz in A. suum adults in 100 µM 5HT, at a temperature 658 
similar to our recordings. In Fig. 8C, switching the perfusate to 1 µM IVM caused most pumping to 659 
cease within 3-4 min. Brownlee et al. (1997) reported that 1 µM IVM inhibited pumping as rapidly 660 
as 60 s after application, in dissected adult A. suum in which drugs were applied directly to the 661 
pharynx. 662 
Because of the limited number of larvae available, we did not generate concentration-663 
response curves for 5HT and IVM on A. suum L3s. Nevertheless, these experiments identified 664 
conditions under which A. suum produced robust pharyngeal pumping in microfluidic EPG chips 665 
and we replicated previous findings in adult A. suum regarding effects of 5HT and IVM on 666 
pharyngeal pumping. Future experiments can now investigate these effects in detail, including 667 
potential differences in pharyngeal physiology and anthelmintic sensitivity between larvae and 668 
adult worms.  669 
 670 
4. Conclusions 671 
 672 
Technological advances often exert outsized influence on the progress of scientific research, 673 
as seen in the case of high-throughput screening for anthelmintic drug candidates (e.g., 674 
Buckingham et al., 2014; Bulman et al., 2015; Burns et al., 2015). The present study addresses 675 
another key aspect of the screening process: secondary screening to prioritize hits and investigate 676 
mode of action. Our work is motivated by the urgent need to develop new anthelmintic treatments 677 
for humans and animals, and the importance of neurotransmitter receptors and ion channels as 678 
potential drug targets. The 8-channel microfluidic EPG chip provides a convenient and powerful 679 
new tool for detecting the integrity of electrophysiological signaling in nematodes and its 680 
perturbation by applied drugs, compounds or natural products. The throughput of the current 8-681 
channel EPG chip can be increased by increasing the number of recording modules per chip, or 682 
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running multiple chips in parallel, but is unlikely to approach the throughput of large, automated 683 
screening platforms. Instead, EPG analysis can help prioritize hits and assist in determining mode 684 
of action: e.g., if used in conjunction with C. elegans mutants or molecular tools such as 685 
transgenesis and RNA interference that are increasingly available in parasitic nematodes (Ward, 686 
2015). Alternatively, when supplies of parasitic worms are limited and/or drug candidates are 687 
expected to have rapid electrophysiological actions, the 8-channel microfluidic EPG platform could 688 
provide a useful primary screen. The experimental design of recording EPGs from individual 689 
worms before and during exposure to a drug (illustrated in Figs. 7A and 8B, 8C) provides a 690 
powerful advantage of within-subjects statistical analysis.  691 
Ultimately, promising anthelmintic compounds must be tested on the actual species being 692 
targeted for control; to advance this capability, we validated the EPG platform in two STH species 693 
relevant to human health in low-resource regions of the world. Specifically, we found that under 694 
suitable conditions, host-stage larvae of A. ceylanicum and A. suum produce robust, sustained 695 
EPG activity in microfluidic chips, allowing stimulatory (Figs. 6 and 8B) or inhibitory (Figs. 7 and 696 
8C) drugs to be readily detected. In contrast to less specific readouts of anthelmintic activity such 697 
as development, motility or death, EPG recordings can provide more direct access to underlying 698 
mechanisms. Furthermore, the ability to rapidly record thousands of EPG waveforms from 699 
individual worms provides exceptional statistical power. This capability may be valuable in 700 
detecting drug-resistant phenotypes, or for distinguishing different species within nematode 701 
populations. To permit the separation of worms based on their EPG phenotype, NemaMetrix 702 
(www.nemametrix.com) is developing a ‘sorting chip’ in which individual worms can be sorted into 703 
separate chambers for discard or recovery (e.g., sorting susceptible and resistant worms based on 704 
pharyngeal pumping that persists in the presence of an anthelmintic drug).  705 
In experiments to be published elsewhere, we have used the microfluidic EPG platform to 706 
screen a library for anthelmintic candidates; demonstrate anthelmintic activity in a natural product 707 
used traditionally as a vermifuge; and investigated C. elegans models of human aging and 708 
disease. We are also optimizing chip design and experimental conditions for microfluidic EPG 709 
recordings from additional species of parasitic and free-living nematodes. We recommend this new 710 
technology as a versatile addition to the experimental toolbox for anthelmintic drug development 711 
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and studies of drug resistance, basic research on nematode feeding behavior, and other 712 
applications in which an electrophysiological readout can provide unique insights into nematode 713 
biology. 714 
  715 
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Table 1. Properties of EPG waveforms during pharyngeal pumping 716 
Species & stage Pump amplitude (µV) Pump duration (ms) 
A. caninum aL3 60 ± 5a,c 62 ± 5 
A. ceylanicum aL3 65 ± 10a,c 139 ± 14d 
A. ceylanicum L4 224 ± 45b 109 ± 10d 
A. suum L3 178 ± 16b 73 ± 3 
 717 
Values are mean ± S.E.M., n = 14 worms/group except A. ceylanicum aL3, n = 8. Mean number of 718 
pumps analyzed per worm was 306 ± 48 pumps (S.E.M., n = 4 groups), recorded under control 719 
conditions. Most A. ceylanicum aL3 recordings were made at room temperature; all others groups 720 
were recorded at ~34-38 oC. Pump amplitude was measured peak-to-peak (E to R spike); a,b 721 
members of these pairs did not differ significantly (p > 0.87); c both aL3 groups differed from the 722 
other groups (p < 0.001). Pump duration was measured as the E to R interval; d the two A. 723 
ceylanicum groups did not differ (p = 0.17) whereas all other groups differed significantly (p < 724 
0.024). Two-tailed Wilcoxon Mann-Whitney U-tests. 725 
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 967 
Legends to Figures 968 
 969 
Fig. 1. Microfluidic EPG recording device. A. Channels were filled with a dye to aid visualization in 970 
this image. Dimensions of the glass substrate of the chip was 5.08 x 7.62 cm, with PDMS layer 971 
above. Worms were loaded into the inlet port (arrow) and distributed via a branching network into 972 
narrowed channel segments (‘worm traps’; see B) located in each of the 8 recording modules. An 973 
electrode (blue wire) was inserted distal to each worm trap and a hollow metal electrode (not 974 
shown) was inserted into the inlet port to deliver perfusate and serve as a common electrical 975 
reference. After flowing past worms, perfusate collected in a row of waste reservoirs (arrow). 976 
Expanded region shown in B is indicated (arrow). B. Enlarged view of a single recording module, 977 
with an A. ceylanicum L4 positioned tail-first in the worm trap. 978 
 979 
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Fig. 2. Microfluidic EPG recordings from activated L3 (aL3) hookworms. A. A. ceylanicum aL3s, in 980 
M9 with 15% HS and 10 mM 5HT, 28 °C. E and R spikes  in the pump waveform are marked in A 981 
and Bi. B. A. caninum aL3s. i. In M9 with 1 mM 5HT, 38 °C. ii. Three worms in one chip, in M9 982 
with 5 mM 5HT, 42 °C. All worms were recorded 1 d a fter in vitro activation. 983 
 984 
Fig. 3. EPG recordings from A. ceylanicum L4s. A. Eight worms recorded simultaneously in one 985 
chip, showing robust EPG activity. The times indicated (i, ii, iii) for worm 8 correspond to the 986 
traces in B. B. EPG waveforms excerpted from worm 8 in A. i, characteristic pump waveform. ii, 987 
waveform that we termed a ‘flutter,’ characterized by rapid voltage deflections. iii, hybrid waveform 988 
with features of both pumps and flutters. C. EPG recordings from six A. ceylanicum L4s in a 989 
different chip, showing typical diversity in EPG waveforms; flutters marked by blue arrowheads. 990 
Recordings made in RPMI-c with 20% CS, 36-38 °C. 991 
 992 
Fig. 4. Simultaneous EPG and video analysis of esophageal (pharyngeal) behavior in A. 993 
ceylanicum L4. The larva was oriented head-first in the worm trap (at right; see Fig. 1B), in RPMI 994 
with 20% CS, 20 °C. The EPG recordings scroll from left to right across the screen, with a vertical 995 
red line indicating the time corresponding to the video display. Video playback was slowed to 30% 996 
of original speed. The audio channel was synthesized from the EPG voltage signal (see 2.8). A. 997 
Esophageal (pharyngeal) pumping. B. The same worm, showing erratic contractions of the 998 
esophagus and EI valve openings, termed flutters. Observing the correspondence between EPG 999 
waveforms and esophageal behaviors is facilitated by listening to the audio track while watching 1000 
the worm video. 1001 
 1002 
Fig. 5. EPG activity in A. ceylanicum L4s under control conditions. A. Protocol for drug perfusion 1003 
experiments. B, C. EPG activity during perfusion with control medium (RPMI-c with 20% CS) with 1004 
(brown) or without (black) switching the perfusate to the same medium at t = 0. Grey bars mask the 1005 
electrical artifact produced by switching perfusate in the switched group. Pump and flutter counts 1006 
were combined and jointly termed EPG ‘events.’ Raw data in B; normalized (see 2.9) data in C 1007 
(dotted line marks normalized frequency of 1.0). Lines and shading show mean + S.E.M. in all 1008 
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panels; n (number of worms) shown in key. D. Cumulative fraction of events (see 2.9) for 45 min 1009 
after the time of the switch in the switched group, or corresponding time in the unswitched group. 1010 
CF50 values (the time at which 50% of the total number of events had occurred) for worms in the 1011 
switched and unswitched groups did not differ significantly (P > 0.3; 2-tailed Wilcoxon Mann-1012 
Whitney U-test). E. Change (∆) in the ‘flutter fraction,’ (the proportion of EPG events that were 1013 
flutters), expressed as the deviation from each worm’s baseline flutter fraction (see 2.9); baseline 1014 
flutter fraction was between 0.006 and 0.8 in both groups (not shown). Dotted line marks zero 1015 
change in flutter fraction. Same data set in B-E. All recordings at 32-37 °C.  1016 
 1017 
Fig. 6. Effect of 5HT on EPG activity in A. ceylanicum L4s. A. Dose-response relationship of 1018 
normalized event frequency (pumps + flutters) versus 5HT concentration. At t = 0 min, perfusate 1019 
was switched (grey bar) from control medium (RPMI-c with 20% CS) to the same medium with 1020 
different concentrations of 5HT (see key). Lines and shading show mean ± S.E.M.; n (number of 1021 
worms) shown in key. Dotted line marks normalized frequency of 1.0. B. Cumulative fraction of 1022 
events for 60 min after switching to 5HT-containing perfusate. CF50 values (dotted line) did not 1023 
differ significantly between groups except for the 0.5 mM 5HT group, which differed from all other 1024 
groups (P < 0.04; 2-tailed Wilcoxon Mann-Whitney U-test). C. Change (∆) in ‘flutter fraction,’ (the 1025 
proportion of total EPG events that were flutters); baseline flutter fraction was between 0.05 and 1026 
0.2 in all groups (not shown). Dotted line marks zero change in flutter fraction. Same data set in A-1027 
C. All recordings at 34-36 °C. 1028 
 1029 
Fig. 7. Effect of IVM on EPG activity in L4 A. ceylanicum. A. Simultaneous EPG recordings from 1030 
seven worms (numbered 1 to 7) in one chip: each trace from a different worm. Control activity was 1031 
recorded in RPMI-c with 20% CS, followed by a switch (grey bar) to the same medium with 1 µM 1032 
IVM. B. Dose-response relationship of normalized event (pumps + flutters) frequency versus IVM 1033 
concentration. Lines and shading show mean ± S.E.M.; n (number of worms) shown in key. Dotted 1034 
line marks normalized frequency of 1.0. C. Cumulative fraction of events for 45 min after switching 1035 
to IVM-containing perfusate. CF50 values (dotted line) differed significantly between all groups (P < 1036 
0.004; 2-tailed Wilcoxon Mann-Whitney U-tests). D. Change (∆) in ‘flutter fraction,’ (the proportion 1037 
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of total EPG events that were flutters); baseline flutter fraction was between 0.05 and 0.2 in all 1038 
groups (not shown). Lines were terminated when EPG activity ceased (1 µM and 10 µM IVM 1039 
groups). Dotted line marks zero change in flutter fraction. Same data set in B-D. All recordings at 1040 
34-36 °C. 1041 
 1042 
Fig. 8. EPG recordings from A. suum L3s. A. Representative EPG recordings during pharyngeal 1043 
pumping by two A. suum L3s in different chips, in RPMI-c with 10% CaS and 1 mM 5HT. B. 1044 
Induction of pharyngeal pumping by 5HT. Simultaneous EPG recordings from 3 worms (numbered 1045 
1 to 3) in one chip: each trace from a different worm. Control period was recorded in RPMI-c with 1046 
10% CaS, followed by a switch (grey bar) to the same medium with 1 mM 5HT. C. Simultaneous 1047 
EPG recordings from six worms (numbered 1 to 6) in one chip: each trace from a different worm. 1048 
Control activity was recorded in RPMI-c with 10% CaS and 1 mM 5HT, followed by a switch (grey 1049 
bar) to the same medium with 1 µM IVM. All recordings at 37-38 °C. 1050 
 1051 
Supplemental Content. Video recording of esophageal pumping in an A. ceylanicum L4. The 1052 
larva was oriented head-first in the worm trap (right), in RPMI with 20% CS, 20 °C. Video playback 1053 
was slowed to 30% of original speed. Five pumps are shown, accompanied by coordinated 1054 
opening and closing of the EI valve. Retrograde perfusate flow is present because perfusion had 1055 
been turned off.  1056 
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Highlights 
• Pharyngeal pumping in nematodes generates an electropharyngeogram (EPG) 
• The EPG provides a readout of the electrical activity of neurons and muscles 
• A microfluidic platform for recording EPGs was validated in parasitic nematodes 
• EPG activity and drug responses were characterized in host-stage larvae 
• Microfluidic EPG recordings provide a powerful new tool for anthelmintic research 
